CLINICAL_TRIALS
trial_result
· 2020-02-05
Clinical Trial Update: Everolimus for Children With NF1 Chemotherapy-Refractory Radiographic Progressive Low Grade Gliomas [Phase 2]
Summary
Phase 2 clinical trial update on everolimus for children with NF1-associated chemotherapy-refractory radiographic progressive low-grade gliomas.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Glioma | Phase 2 | Status: COMPLETED | Results posted: 2020-02-05